Thursday, January 21, 2016 9:47:46 AM
__________________________________________________
Consensus Ratings for Cancer Genetics (NASDAQ:CGIX)
Ratings Breakdown: 3 Buy Rating(s)
Consensus Rating: Buy (Score: 3.00)
Consensus Price Target: $13.00 (493.61% upside)
___________________________________________________
http://www.marketbeat.com/stocks/NASDAQ/CGIX/
Was hoping it would jump out of the gate, but BIB and IBB are both down 2-4% -- need a reversal like yesterday.
CGIX
VHAI - Vocodia Partners with Leading Political Super PACs to Revolutionize Fundraising Efforts • VHAI • Sep 19, 2024 11:48 AM
Dear Cashmere Group Holding Co. AKA Swifty Global Signs Binding Letter of Intent to be Acquired by Signing Day Sports • DRCR • Sep 19, 2024 10:26 AM
HealthLynked Launches Virtual Urgent Care Through Partnership with Lyric Health. • HLYK • Sep 19, 2024 8:00 AM
Element79 Gold Corp. Appoints Kevin Arias as Advisor to the Board of Directors, Strengthening Strategic Leadership • ELMGF • Sep 18, 2024 10:29 AM
Mawson Finland Limited Further Expands the Known Mineralized Zones at Rajapalot: Palokas step-out drills 7 metres @ 9.1 g/t gold & 706 ppm cobalt • MFL • Sep 17, 2024 9:02 AM
PickleJar Announces Integration With OptCulture to Deliver Holistic Fan Experiences at Venue Point of Sale • PKLE • Sep 17, 2024 8:00 AM